reckamp the role of angiogenesis in previously treated nsclc
Published 6 years ago • 140 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
9:19
gracecast-004_lung-cancer_antiangiogenesis in first line nsclc
-
6:42
maintenance systemic therapy: the nrg-lu trial - onctalk lung 2023
-
7:55
what is a bone marrow transplant? - blood cancer onctalk 2023
-
6:20
oncogene-driven metastatic nsclc: frontline treatment & resistance mechanisms - onctalk 2022
-
3:21
q&a: treatment options for patients with leptomeningeal disease - targeted therapies in lung cancer
-
4:51
targeted therapy side effects - lcvl 2024
-
5:07
christie’s story: metastatic lung cancer survivor
-
57:04
the medicine of energy: biofields & cellular regeneration workshop
-
3:34
transplants in myeloma and lymphoma: effects on survival - blood cancer onctalk 2023
-
2:45:23
full videoondemand blood cancers onctalk 2024
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
3:37
gracecastuc-022_lung_what is an inherited t790m egfr mutation, and what does it mean?
-
8:09
gracecast - lcvl -can local therapies improve outcomes for stage iv nsclc?
-
4:37
targeted therapy in lung cancer: the importance of biomarkers - lcvl 2024
-
2:52
location of disease: can metastatic locations predict success of treatment? - onctalk 2022
-
1:55
how do i find clinical trials? - blood cancer onctalk
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
5:30:11
full event mainstage 2023 targeted therapies in lung cancer patient forum on-demand
-
7:23
autologous bone marrow transplants: use in myeloma and lymphoma - blood cancer onctalk 2023
-
2:02
what is the role for pd l1 testing for adv.nsclc in initial diagnosis
-
4:12
trials for patients with actionable mutations, & the importance of quality of life - onctalk 2022
-
2:01
egfr 돌연변이 폐암 치료 - east asian lcvl 2024